Annual Accounts Payable
$1.70 M
+$424.00 K+33.31%
31 December 2022
Summary:
Nymox Pharmaceutical annual accounts payable is currently $1.70 million, with the most recent change of +$424.00 thousand (+33.31%) on 31 December 2022. During the last 3 years, it has risen by +$294.00 thousand (+20.96%).NYMX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
N/A
31 March 2023
Summary:
Nymox Pharmaceutical quarterly accounts payable is not available.NYMX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NYMX Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +21.0% | - |
| 5 y5 years | +110.0% | - |
NYMX Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -28.9% |
Nymox Pharmaceutical Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $1.70 M(+33.3%) | $1.70 M(+33.3%) |
| Dec 2021 | $1.27 M(-9.3%) | $1.27 M(-9.3%) |
| Dec 2020 | $1.40 M(-13.9%) | $1.40 M(-13.9%) |
| Dec 2019 | $1.63 M(+101.6%) | $1.63 M(+101.6%) |
| Dec 2018 | $808.00 K(-59.9%) | $808.00 K(-59.9%) |
| Dec 2017 | $2.02 M(+76.6%) | $2.02 M(+76.6%) |
| Dec 2016 | $1.14 M(-37.9%) | $1.14 M(+12.4%) |
| June 2016 | - | $1.02 M(+9.2%) |
| Mar 2016 | - | $930.00 K(-49.5%) |
| Dec 2015 | $1.84 M(+24.0%) | $1.84 M(+20.4%) |
| June 2015 | - | $1.53 M(-12.6%) |
| Mar 2015 | - | $1.75 M(+17.8%) |
| Dec 2014 | $1.48 M(+7.3%) | $1.48 M(+1.3%) |
| Sept 2014 | - | $1.47 M(-20.3%) |
| June 2014 | - | $1.84 M(+5.7%) |
| Mar 2014 | - | $1.74 M(+25.7%) |
| Dec 2013 | $1.38 M(+57.1%) | $1.38 M(+147.2%) |
| Sept 2013 | - | $559.50 K(-51.2%) |
| June 2013 | - | $1.15 M(-3.1%) |
| Mar 2013 | - | $1.18 M(+34.2%) |
| Dec 2012 | $880.50 K(+37.5%) | $880.50 K(+2.0%) |
| Sept 2012 | - | $863.30 K(+26.7%) |
| June 2012 | - | $681.60 K(+82.2%) |
| Mar 2012 | - | $374.00 K(-41.6%) |
| Dec 2011 | $640.50 K(-73.2%) | $640.50 K(+61.4%) |
| Sept 2011 | - | $396.80 K(-8.9%) |
| June 2011 | - | $435.50 K(-13.9%) |
| Mar 2011 | - | $505.80 K(-78.8%) |
| Dec 2010 | $2.39 M(+59.7%) | $2.39 M(+43.4%) |
| Sept 2010 | - | $1.66 M(+10.6%) |
| June 2010 | - | $1.50 M(+27.8%) |
| Mar 2010 | - | $1.18 M(-21.2%) |
| Dec 2009 | $1.49 M(+38.5%) | $1.49 M(+27.2%) |
| Sept 2009 | - | $1.18 M(-4.4%) |
| June 2009 | - | $1.23 M(+5.8%) |
| Mar 2009 | - | $1.16 M(+7.6%) |
| Dec 2008 | $1.08 M(-0.3%) | $1.08 M(-15.5%) |
| Sept 2008 | - | $1.28 M(-4.6%) |
| June 2008 | - | $1.34 M(+8.9%) |
| Mar 2008 | - | $1.23 M(+13.5%) |
| Dec 2007 | $1.08 M | $1.08 M(+25.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2007 | - | $859.60 K(+8.3%) |
| June 2007 | - | $793.90 K(-27.0%) |
| Mar 2007 | - | $1.09 M(-24.0%) |
| Dec 2006 | $1.43 M(-16.0%) | $1.43 M(-1.0%) |
| Sept 2006 | - | $1.45 M(+26.2%) |
| June 2006 | - | $1.15 M(-39.7%) |
| Mar 2006 | - | $1.90 M(+11.6%) |
| Dec 2005 | $1.70 M(+33.7%) | $1.70 M(+18.6%) |
| Sept 2005 | - | $1.44 M(+2.6%) |
| June 2005 | - | $1.40 M(-5.0%) |
| Mar 2005 | - | $1.47 M(+15.7%) |
| Dec 2004 | $1.27 M(+4.6%) | $1.27 M(-3.1%) |
| Sept 2004 | - | $1.32 M(-16.9%) |
| June 2004 | - | $1.58 M(+72.9%) |
| Mar 2004 | - | $916.10 K(-24.8%) |
| Dec 2003 | $1.22 M(+39.9%) | $1.22 M(+44.4%) |
| Sept 2003 | - | $843.70 K(+24.1%) |
| June 2003 | - | $679.90 K(+24.6%) |
| Mar 2003 | - | $545.80 K(-37.3%) |
| Dec 2002 | $870.90 K(+194.8%) | $870.90 K(+57.0%) |
| Sept 2002 | - | $554.70 K(-16.9%) |
| June 2002 | - | $667.50 K(+24.6%) |
| Mar 2002 | - | $535.70 K(+81.3%) |
| Dec 2001 | $295.40 K(-8.8%) | $295.40 K(-5.4%) |
| Sept 2001 | - | $312.30 K(-13.7%) |
| June 2001 | - | $361.80 K(+84.7%) |
| Mar 2001 | - | $195.90 K(-39.5%) |
| Dec 2000 | $323.80 K(-33.5%) | $323.80 K(+17.1%) |
| Sept 2000 | - | $276.40 K(-46.1%) |
| June 2000 | - | $512.70 K(-15.1%) |
| Mar 2000 | - | $604.10 K(+24.1%) |
| Dec 1999 | $486.90 K(+61.8%) | $486.90 K(+143.7%) |
| Sept 1999 | - | $199.80 K(+100.8%) |
| June 1999 | - | $99.50 K(-50.3%) |
| Mar 1999 | - | $200.10 K(-33.5%) |
| Dec 1998 | $301.00 K(+50.7%) | $301.00 K(+200.4%) |
| Sept 1998 | - | $100.20 K(+0.1%) |
| June 1998 | - | $100.10 K(+0.2%) |
| Mar 1998 | - | $99.90 K(-50.0%) |
| Dec 1997 | $199.80 K | $199.80 K(+99.8%) |
| Sept 1997 | - | $100.00 K(-50.0%) |
| June 1997 | - | $200.00 K |
FAQ
- What is Nymox Pharmaceutical annual accounts payable?
- What is the all time high annual accounts payable for Nymox Pharmaceutical?
- What is the all time high quarterly accounts payable for Nymox Pharmaceutical?
What is Nymox Pharmaceutical annual accounts payable?
The current annual accounts payable of NYMX is $1.70 M
What is the all time high annual accounts payable for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high annual accounts payable is $2.39 M
What is the all time high quarterly accounts payable for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high quarterly accounts payable is $2.39 M